Skip to content

908 Devices MASS EPS (Diluted)

EPS (Diluted) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.43+11.3%
WAT
Waters CorporationWAT
-$0.87-143%
Agilent Technologies logo
Agilent TechnologiesA
$1.20+60.0%
Bruker logo
BrukerBRKR
$0.02-81.8%
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD
$8.33+6.7%
Danaher logo
DanaherDHR
$1.45+9.8%

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total equity$134.2M-15.8%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp
FCF margin-16.7%-7.2pp

Returns & leverage

See full
Return on equity-24.6%-149pp
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Reported directly by 908 Devices in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: 908 Devices’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's EPS (diluted)?
908 Devices (MASS) reported EPS (diluted) of -$0.32 in Q1 2026.
How has 908 Devices's EPS (diluted) changed year-over-year?
908 Devices's EPS (diluted) decreased by 126.0% year-over-year, from $1.23 to -$0.32.
What is the long-term trend for 908 Devices's EPS (diluted)?
Over 4 years (2021 to 2025), 908 Devices's EPS (diluted) has grown at a -8.2% compound annual growth rate (CAGR), from -$0.79 to $0.56.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.